Axovant Sciences Ltd (NQ: AXON )

1.220 USD UNCHANGED

Last Price Updated: 6:35 PM EST, Feb 13, 2019 Add to My Watchlist

Price and Volume

Volume	0
Open	1.220
Bid (Size)	1.230 (4)
Ask (Size)	1.240 (14)
Prev. Close	1.220
Today's Range	1.220 - 1.220
52wk Range	N/A - N/A
Shares Outstanding	107,788,074
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News

Axovant Announces Formation of Arvelle Therapeutics and Strategic Transition of Legacy Small Molecule Team Into Newly Formed Company

February 13, 2019

Axovant Sciences (NASDAQ: AXGT), a clinical-stage company developing innovative gene therapies, today announces the formation of Arvelle Therapeutics and the strategic transition of its legacy small...

Axovant Announces Third Fiscal Quarter 2018 Financial Results and Corporate Updates

February 07, 2019

Axovant Sciences (NASDAQ: AXON), a clinical-stage company developing innovative gene therapies, today provided financial results and corporate updates for its third fiscal quarter and nine months ended...

Performance

More News

Axovant Announces Presentation at J.P. Morgan Healthcare Conference and Anticipated 2019 Clinical Development Milestones

January 02, 2019

Roivant Sciences to Present at the 37th Annual J.P. Morgan Healthcare Conference

January 02, 2019

Detailed Research: Economic Perspectives on Canopy Growth, ArQule, MoneyGram International, Teradata, Clovis Oncology, and Axovant Sciences — What Drives Growth in Today's Competitive Landscape

December 25, 2018

Hercules Capital Announces Multiple Outstanding Achievements by Numerous Investment Portfolio Companies

February 11, 2019

Roivant Sciences and Daiichi Sankyo Enter into Broad Pipeline Partnership

December 18, 2018

Axovant Sciences Announces Pricing of $30 Million Public Offering of Common Shares

December 14, 2018

Axovant Sciences Announces Public Offering of Common Shares

December 13, 2018

Axovant Licenses Investigational Gene Therapies for GM1 Gangliosidosis, Tay-Sachs and Sandhoff Diseases from University of Massachusetts Medical School

December 13, 2018

Here's Why Axovant Gene Therapies Rocketed Higher Today

March 11, 2019

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.